Delivered on 2025 Guidance and Strong Operational Execution
Met full-year production, all-in sustaining cost (AISC) and capital guidance; all four sites increased gold production in Q4 2025 and every site met guidance for the year.
Record Financial Performance
Set multiple records in 2025 including record annual adjusted EBITDA (~$1.0 billion), EBITDA margins, net profit, adjusted earnings per share (roughly doubled YoY), operating cash flow and free cash flow (annual free cash flow $543 million).
Exceptional Free Cash Flow Quarter
Generated record Q4 free cash flow of $259 million — exceeding the total free cash flow generated in all of 2024 in a single quarter.
Strong Balance Sheet and Liquidity
Ended the quarter with cash of $477 million (up 42% from prior quarter), zero debt, and no gold hedges, prepays or financing royalties — described as the strongest balance sheet in the company's history.
Material Shareholder Returns
Returned just over $200 million to shareholders in 2025 (doubled quarterly dividend and increased share buyback) and announced 2026 capital returns of up to $432 million (112% increase YoY) via a tripled quarterly dividend and doubled buyback.
Compelling 2026 Guidance (Midpoint)
2026 guidance projects ~12% higher gold production vs. 2025 and ~7% lower AISC at the midpoint; Haile expected to drive growth with ~35% higher production and ~25% lower unit cost in 2026.
Significant Exploration and Growth Investment
Planned exploration/growth capital up materially — exploration capital planned up 2.5x to $340 million (management also cited a 50% increase in exploration spend), accelerating Waihi North development, commencing Palomino underground at Haile and increased drilling across assets.
Site-specific Operational Metrics
Q4 site production: Haile 56,000 oz, Macraes 56,000 oz, Waihi ~22,000 oz, Didipio ~24,000 oz and 3,200 t copper. Macraes Q4 AISC under $1,300/oz. Updated technical reports for Haile and Macraes scheduled for end of March with positive outlooks (Haile >200k oz/yr 2026–2031 at updated plan; Macraes life extension to 2032 at $2,200/oz).